Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hypertension

  Free Subscription

Articles published in
Eur Heart J
    January 2018
  1. MESSERLI FH, Rimoldi SF, Bangalore S
    Changing definition of hypertension in guidelines: how innocent a number game?
    Eur Heart J. 2018 Jan 9. pii: 4794716. doi: 10.1093.
    >> Share

    December 2017
  2. GALIE N, Manes A, Dardi F, Palazzini M, et al
    Aiming at the appropriate target for the treatment of pulmonary hypertension due to left heart disease.
    Eur Heart J. 2017 Dec 27. pii: 4780182. doi: 10.1093.
    >> Share

  3. BERMEJO J, Yotti R, Garcia-Orta R, Sanchez-Fernandez PL, et al
    Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.
    Eur Heart J. 2017 Dec 21. pii: 4769387. doi: 10.1093.
    >> Share

    November 2017
  4. LUSCHER TF
    From 'essential' hypertension to intensive blood pressure lowering: the pros and cons of lower target values.
    Eur Heart J. 2017;38:3258-3271.
    >> Share

    October 2017
  5. RUIZ-HURTADO G, Ruilope LM
    Advantages of sacubitril/valsartan beyond blood pressure control in arterial hypertension.
    Eur Heart J. 2017 Oct 20. doi: 10.1093.
    >> Share

  6. LUSCHER TF
    Special issues in heart failure: pulmonary hypertension, deranged potassium levels, and haemodynamic profiles.
    Eur Heart J. 2017;38:2857-2859.
    >> Share

    September 2017
  7. SCHMIEDER RE, Wagner F, Mayr M, Delles C, et al
    The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.
    Eur Heart J. 2017 Sep 27. doi: 10.1093.
    >> Share

  8. AOKI T, Sugimura K, Tatebe S, Miura M, et al
    Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications.
    Eur Heart J. 2017 Sep 23. doi: 10.1093.
    >> Share

    June 2017
  9. WEATHERALD J, Sitbon O, Humbert M
    Validation of a risk assessment instrument for pulmonary arterial hypertension.
    Eur Heart J. 2017 Jun 13. doi: 10.1093.
    >> Share

  10. KYLHAMMAR D, Kjellstrom B, Hjalmarsson C, Jansson K, et al
    A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.
    Eur Heart J. 2017 Jun 1. doi: 10.1093.
    >> Share

    May 2017
  11. PATEL RS, Masi S, Taddei S
    Understanding the role of genetics in hypertension.
    Eur Heart J. 2017 May 25. doi: 10.1093.
    >> Share

  12. MAHFOUD F, Schmieder RE, Azizi M, Pathak A, et al
    Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future.
    Eur Heart J. 2017 May 5. doi: 10.1093.
    >> Share

    April 2017
  13. NIIRANEN TJ, McCabe EL, Larson MG, Henglin M, et al
    Risk for hypertension crosses generations in the community: a multi-generational cohort study.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    >> Share

  14. LUSCHER TF
    From systemic and pulmonary hypertension to heart failure: novel drugs and devices.
    Eur Heart J. 2017;38:1087-1090.
    >> Share

  15. FUKS KB, Weinmayr G, Basagana X, Gruzieva O, et al
    Long-term exposure to ambient air pollution and traffic noise and incident hypertension in seven cohorts of the European study of cohorts for air pollution effects (ESCAPE).
    Eur Heart J. 2017;38:983-990.
    >> Share

    March 2017
  16. VAN EMPEL V, Knackstedt C, van Paassen P, Brunner-La Rocca HP, et al
    Just air good enough in pulmonary hypertension?
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    >> Share

  17. ULRICH S, Hasler ED, Saxer S, Furian M, et al
    Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial.
    Eur Heart J. 2017 Mar 11. doi: 10.1093.
    >> Share

    February 2017
  18. GALIE N, Jansa P, Pulido T, Channick RN, et al
    SERAPHIN haemodynamic sub-study: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.
    Eur Heart J. 2017 Feb 28. doi: 10.1093.
    >> Share

  19. VAN DER FEEN DE, Bartelds B, de Boer RA, Berger RM, et al
    Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease.
    Eur Heart J. 2017 Feb 23. doi: 10.1093.
    >> Share

    January 2017
  20. MANCIA G, Oparil S, Whelton PK, McKee M, et al
    The technical report on sodium intake and cardiovascular disease in low- and middle-income countries by the joint working group of the World Heart Federation, the European Society of Hypertension and the European Public Health Association.
    Eur Heart J. 2017 Jan 21. pii: ehw549. doi: 10.1093.
    >> Share

  21. LIP GY, Coca A
    Hypertension and cardiac arrhythmias.
    Eur Heart J. 2017;38:223-225.
    >> Share

  22. KROGAGER ML, Torp-Pedersen C, Mortensen RN, Kober L, et al
    Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data.
    Eur Heart J. 2017;38:104-112.
    >> Share

  23. MAHFOUD F, Bakris G, Bhatt DL, Esler M, et al
    Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry.
    Eur Heart J. 2017;38:93-100.
    >> Share

  24. PITT B, Rossignol P
    The association between serum potassium and mortality in patients with hypertension: 'a wake-up call'.
    Eur Heart J. 2017;38:113-115.
    >> Share

  25. LUSCHER TF
    Hypertension: detection, mechanisms, outcomes, and treatment.
    Eur Heart J. 2017;38:67-69.
    >> Share

    December 2016
  26. HOEPER MM, Lam CS, Vachiery JL, Bauersachs J, et al
    Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further researchdagger.
    Eur Heart J. 2016 Dec 23. pii: ehw597. doi: 10.1093.
    >> Share

    November 2016
  27. FRANKLIN SS, O'Brien E, Staessen JA
    Masked hypertension: understanding its complexity.
    Eur Heart J. 2016.
    >> Share

    October 2016
  28. BRUNO RM, Taddei S
    Renal denervation: a blunt weapon against isolated systolic hypertension?
    Eur Heart J. 2016.
    >> Share

    July 2016
  29. MAHFOUD F, Bakris G, Bhatt DL, Esler M, et al
    Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry.
    Eur Heart J. 2016.
    >> Share

  30. LOBO MD, Sobotka PA, Pathak A
    Interventional procedures and future drug therapy for hypertension.
    Eur Heart J. 2016.
    >> Share

  31. PITT B, Rossignol P
    The association between serum potassium and mortality in patients with hypertension: 'a wake-up call'.
    Eur Heart J. 2016.
    >> Share

    May 2016
  32. LUSCHER TF
    Frontiers in congenital heart disease: pulmonary hypertension, heart failure, and arrhythmias.
    Eur Heart J. 2016;37:1407-9.
    >> Share

    April 2016
  33. KROGAGER ML, Torp-Pedersen C, Mortensen RN, Kober L, et al
    Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data.
    Eur Heart J. 2016.
    >> Share

    March 2016
  34. LUSCHER TF
    Update on hypertension: target blood pressure, comorbidities, and outcome.
    Eur Heart J. 2016;37:921-3.
    >> Share

  35. MUNZEL T, Gori T, Schmidt F
    CardioPulse. Noise pollution and arterial hypertension.
    Eur Heart J. 2016;37:933-6.
    >> Share

  36. EWEN S, Zivanovic I, Bohm M, Mahfoud F, et al
    CardioPulse. Catheter-based renal denervation for hypertension treatment: update 2015.
    Eur Heart J. 2016;37:930-3.
    >> Share

  37. LOBO MD, Paton JF
    CardioPulse. The use of devices to treat hypertension.
    Eur Heart J. 2016;37:927-9.
    >> Share

  38. OPARIL S
    CardioPulse. The SPRINT trial results.
    Eur Heart J. 2016;37:924-7.
    >> Share

  39. LUSCHER TF, Sudano I
    SPRINT: the race for optimal blood pressure control.
    Eur Heart J. 2016;37:937-41.
    >> Share

  40. NISHIO M, Hirooka K, Doi Y
    Chinese herbal drug natural indigo may cause pulmonary artery hypertension.
    Eur Heart J. 2016.
    >> Share

  41. STOEKENBROEK RM, Boekholdt SM, Luben R, Hovingh GK, et al
    Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study.
    Eur Heart J. 2016;37:880-9.
    >> Share

    February 2016
  42. HAN QJ, Contijoch F, Forfia PR, Han Y, et al
    Four-dimensional flow magnetic resonance imaging visualizes drastic changes in the blood flow in a patient with chronic thromboembolic pulmonary hypertension after pulmonary thromboendarterectomy.
    Eur Heart J. 2016.
    >> Share

  43. SKRIDE A, Sablinskis K, Klepetko W, Lang I, et al
    Choriocarcinoma mimicking chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2016.
    >> Share


  44. Erratum to 'Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans'.
    Eur Heart J. 2016.
    >> Share

    January 2016
  45. CHIBANA H, Tahara N, Itaya N, Sasaki M, et al
    Optical frequency-domain imaging and pulmonary angioscopy in chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2016.
    >> Share

  46. LUSCHER TF
    Pulmonary hypertension, gender issues, and quality of care.
    Eur Heart J. 2016;37:1-3.
    >> Share

  47. HUMBERT M, Galie N
    The Ten Commandments for 2015 European Society of Cardiology-European Respiratory Society Guidelines on Pulmonary Hypertension.
    Eur Heart J. 2016;37:5.
    >> Share

  48. REGITZ-ZAGROSEK V, Oertelt-Prigione S, Prescott E, Franconi F, et al
    Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes.
    Eur Heart J. 2016;37:24-34.
    >> Share

    November 2015
  49. MANCIA G, Kjeldsen SE, Zappe DH, Holzhauer B, et al
    Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Eur Heart J. 2015.
    >> Share

    August 2015
  50. PERRONE-FILARDI P, Paolillo S, Costanzo P, Savarese G, et al
    The role of metabolic syndrome in heart failure.
    Eur Heart J. 2015.
    >> Share

    June 2015
  51. GUTIERREZ A, Bhatt DL
    Medical management of peripheral artery disease in diabetes mellitus.
    Eur Heart J. 2015;36:1494-5.
    >> Share

    May 2015
  52. HILFIKER-KLEINER D, Haghikia A, Nonhoff J, Bauersachs J, et al
    Peripartum cardiomyopathy: current management and future perspectives.
    Eur Heart J. 2015;36:1090-7.
    >> Share

  53. KARANASOS A, Van Mieghem NM, Regar E, Daemen J, et al
    Serial imaging observations of vascular healing in a denervation-induced renal artery dissection.
    Eur Heart J. 2015;36:1040.
    >> Share

    April 2015
  54. LUSCHER TF
    An update on heart failure and peripheral arterial disease.
    Eur Heart J. 2015;36:885-7.
    >> Share

    March 2015
  55. RAM VS
    CardioPulse: the burden of cardiovascular disease in India.
    Eur Heart J. 2015;36:704-5.
    >> Share


  56. Renal denervation more successful when it includes accessory arteries.
    Eur Heart J. 2015;36:536.
    >> Share

  57. MASON E, Tofield A
    New analysis of the SYMPLICITY HTN-3 trial.
    Eur Heart J. 2015;36:535.
    >> Share

  58. TAYLOR J
    European Society of Cardiology launches Council on Hypertension.
    Eur Heart J. 2015;36:532-3.
    >> Share

  59. MESSERLI FH, Bangalore S, Schmieder RE
    Wilder's principle: pre-treatment value determines post-treatment response.
    Eur Heart J. 2015;36:576-9.
    >> Share

    February 2015
  60. SCHNOHR P, Marott JL, Kristensen TS, Gyntelberg F, et al
    Ranking of psychosocial and traditional risk factors by importance for coronary heart disease: the Copenhagen City Heart Study.
    Eur Heart J. 2015.
    >> Share

    January 2015
  61. JACKSON CE, Castagno D, Maggioni AP, Kober L, et al
    Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis.
    Eur Heart J. 2015.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016